Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOCUST: Vytorin vs Simvastatin in Low-Carb Diet
NCT00566267Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ezetimibe in hyperlipidemia, sponsored by Merck & Co.. Started Apr 2006; status: completed.
02
Drugs
ezetimibe
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00566267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566267.